Presented at ACMG 2024 by Genomenon’s Amina Kozaric, this study estimates the genetic prevalence of PLA2G6-associated neurodegeneration, which is an early onset progressive neurodegenerative disease.

Presented at ACMG 2024 by Genomenon’s Amina Kozaric, this study estimates the genetic prevalence of PLA2G6-associated neurodegeneration, which is an early onset progressive neurodegenerative disease.
